PWPrashantkumar Waghe

Prashantkumar Waghe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Prashantkumar Waghe has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • B. Rudresh Gowda

    Department of Veterinary Pharmacology and Toxicology, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru, India

    1 shared publication
  • D. Ganeshkumar

    Department of Veterinary Pharmacology and Toxicology, Karnataka Veterinary, Animal and Fisheries Sciences University, Veterinary College, Bidar - 585401, Karnataka, India

    1 shared publication
  • Devendra Pathak

    Department of Veterinary Anatomy College of Veterinary Sciences , GADVASU, Ludhiana 141004 , Punjab

    1 shared publication
  • G. R. Shivaprasad

    Department of Veterinary Pharmacology and Toxicology, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru, India

    1 shared publication
  • Harikumar Sankaran Kutty

    Indian Veterinary Research Institute

    1 shared publication
  • K. R. Anjan Kumar

    Department of Veterinary Pathology, Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru, India

    1 shared publication

Latest Publications

  • Therapeutic Effects of Silymarin on Sodium Arsenite-Induced Myocardial Toxicity in Wistar Rats

    by T. Gurukiran, Prashantkumar Waghe, M. Vijaykumar, Shrikant Kulkarni, Sanganagouda Patil, L. R. Ananthakrishna, Sabha Kounin, M. A. Baseer, D. Ganeshkumar

    Sodium (meta) Arsenite (SA), a widely encountered environmental metalloid, poses substantial cardiovascular hazards, especially in regions affected by contaminated drinking water. Silymarin (SM), a flavonolignan complex known for its antioxidant, anti-inflammatory, and cytoprotective actions, has gained attention for its potential to counter chemical- induced tissue damage. The present study investigated the cardioprotective role of SM against subacute SA-induced cardiovascular toxicity in male Wistar rats. Twenty-four rats were randomly assigned into four groups (n = 6) : Control, SM alone (100 mg/kg administered orally from day 14), SA alone (10 mg/kg in drinking water for 28 days), and SA + SM. Physiological parameters, body weight, feed and water intake were routinely monitored. On day 29, animals were euthanized and samples were collected for biochemical, and histopathological evaluations. SA exposure caused reduced water intake, feed intake, and poor body weight gain. Hematological analysis showed that SA reduced RBC count, hemoglobin, and platelets and increased CK-MB. SA markedly elevated superoxide anion, lipid peroxidation, depleted GSH, and reduced antioxidant enzyme activities. TNF-α levels and cardiac mRNA expression were significantly up-regulated. Histopathology of the heart revealed hemorrhage, myocardial necrosis, fiber disintegration, and inflammatory cell infiltration.Treatment with SM improved physiological, hematological, and biochemical (CK-MB) parameters, restored antioxidant status, suppressed TNF-α levels and mRNA expression, and enhanced myocardial structural integrity. SA induced marked cardiotoxicity characterized by oxidative stress, inflammation, hematological alterations, elevated CK- MB, and myocardial structural damage. SM significantly reversed these changes by restoring antioxidant status, reducing TNF-α–mediated inflammation, and improving cardiac tissue integrity, demonstrating a protective effect against established arsenic-induced cardiotoxicity. These findings indicate that SM exhibits significant therapeutic potential in ameliorating established SA-induced cardiotoxicity, warranting further mechanistic and clinical investigation.

  • Effect of Telmisartan on Arsenic-Induced (Sub-chronic) Perturbations in Redox Homeostasis, Pro-inflammatory Cascade and Aortic Dysfunction in Wistar Rats

    by B. Rudresh Gowda, N. Prakash, C. R. Santhosh, B. H. Pavithra, Rashmi Rajashekaraiah, M. L. Sathyanarayana, Suguna Rao, Prashantkumar Waghe, K. R. Anjan Kumar, G. R. Shivaprasad, et al.

    An experimental study was conducted in male Wistar rats to explore the antioxidant potential of telmisartan (an AT1 receptor blocker) to overcome arsenic (‘As’)-induced perturbations in redox homeostasis pro-inflammatory cytokines, prostaglandin-E2 levels and aortic dysfunction in Wistar rats. Wistar rats were randomly divided into four groups of six each. Group-I served as untreated control, while group-II received sodium (meta) arsenite (NaAsO2) (10 mg/kg b.wt. p.o) for a period of 60 days. Experimental rats in group-III received treatment similar to group-II, but in addition received telmisartan (with 1% aqueous solution of Tween 80) @ 10 mg/kg b.wt. (p.o) for a similar duration, while rats in group-IV received telmisartan alone. Arsenic exposure resulted in significant (p < 0.05) elevation in the levels of superoxide anion (\({\mathrm{O}}_2\overline{\cdot}\)) radicals (control: 768.20 ± 126.77 vs group-II: 1232.75 ± 97.85 pmol of NBT reduced/min/mg protein). Telmisartan administration showed significant (p < 0.05) reduction in \({\mathrm{O}}_2\overline{\cdot}\) generation (815.34 ± 43.41 pmol of NBT reduced/min/mg protein). Sub-chronic exposure to ‘As’ significantly (p < 0.05) decreased the activities of SOD, CAT, GPx and GR activity and GSH levels in the aorta, thus induced lipid peroxidation (LPO) measured as measured in terms of thiobarbituric acid reactive substances (TBARS) called as malondialdehyde (MDA). However, the administration of telmisartan effectively countered the LPO (24.03 ± 1.18 nmol of MDA/g) on account of restoring the levels of aforesaid antioxidant defense system. Telmisartan administration effectively attenuated the ‘As’-induced surge in pro-inflammatory cytokines (viz., IL-1β, IL-6 and TNF-α) levels, as well as countered the activity of cyclooxygenase (COX2) as indicated by a significant (p < 0.05) decrease in PGE2 level in the aorta. In addition to it, there was a significant (p < 0.05) decrease in plasma angiotensin II (Ang-II) levels in experimental rats receiving telmisartan. Quantitative RT-PCR studies revealed that sub-chronic exposure to ‘As’ upregulated the Nox2 mRNA expression, but there was a 1.2-fold reduction in expression level upon co-administration of telmisartan. Histopathological examination revealed marked recovery from ‘As’-induced disruption of tunica adventitia and loss of connective tissue in experimental rats receiving telmisartan. The study concludes that telmisartan can overcome aortic dysfunction induced by sub-chronic exposure to arsenic through drinking water in experimental rats through restoration of redox balance, attenuation of pro-inflammatory cytokines and mediators and downregulation of Nox2 mRNA expression.


  • Subchronic Arsenic Exposure Through Drinking Water Alters Lipid Profile and Electrolyte Status in Rats

    by Prashantkumar Waghe, Souvendra Nath Sarkar, Thengumpallil Sasindran Sarath, Kannan Kandasamy, Soumen Choudhury, Priyanka Gupta, Sankarankutty Harikumar, Santosh Kumar Mishra

    Arsenic is a groundwater pollutant and can cause various cardiovascular disorders in the exposed population. The aim of the present study was to assess whether subchronic arsenic exposure through drinking water can induce vascular dysfunction associated with alteration in plasma electrolytes and lipid profile. Rats were exposed to arsenic as 25, 50, and 100 ppm of sodium arsenite through drinking water for 90 consecutive days. On the 91st day, rats were sacrificed and blood was collected. Lipid profile and the levels of electrolytes (sodium, potassium, and chloride) were assessed in plasma. Arsenic reduced high-density lipoprotein cholesterol (HDL-C) and HDL-C/LDL-C ratio, but increased the levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and electrolytes. The results suggest that the arsenic-mediated dyslipidemia and electrolyte retention could be important mechanisms in the arsenic-induced vascular disorder.


  • Subchronic Arsenic Exposure Through Drinking Water Alters Vascular Redox Homeostasis and Affects Physical Health in Rats

    by Prashantkumar Waghe, Thengumpallil Sasindran Sarath, Priyanka Gupta, Harikumar Sankaran Kutty, Kannan Kandasamy, Santosh Kumar Mishra, Souvendra Nath Sarkar

    We evaluated whether arsenic can alter vascular redox homeostasis and modulate antioxidant status, taking rat thoracic aorta as a model vascular tissue. In addition, we evaluated whether the altered vascular biochemical homeostasis could be associated with alterations in the physical indicators of toxicity development. Rats were exposed to arsenic as 25, 50, and 100 ppm of sodium arsenite through drinking water for 90 consecutive days. Body weight, food intake, and water consumption were recorded weekly. On the 91st day, rats were sacrificed; vital organs and thoracic aorta were collected. Lipid peroxidation, reactive oxygen species generation, and antioxidants were assessed in the thoracic aorta. Arsenic increased aortic lipid peroxidation and hydrogen peroxide generation while decreased reduced glutathione content in a dose-dependent manner. The activities of the enzymatic antioxidants superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase were decreased. Further, arsenic at 100 ppm decreased feed intake, water consumption, and body weight from the 11th week onward. At this concentration, arsenic increased the relative weights of the liver and kidney. The results suggest that arsenic causes dose-dependent oxidative stress, reduction in antioxidative defense systems, and body weight loss with alteration in hepato-renal organosomatic indices. Overall, subchronic arsenic exposure through drinking water causes alteration in vascular redox homeostasis and at high concentration affects physical health.


  • Testicular damage after chronic exposure to carbendazim in male goats

    by Waghe Prashantkumar, R.S. Sethi, Devendra Pathak, S. Rampal, S.P.S. Saini

    The present investigation was aimed to determine the effect of chronic exposure of carbendazim on cellular changes in testes of male goats. The goats were randomly divided into two groups, control and treatment (N = 7 each). The treatment group was exposed to carbendazim at the dose rate of 50 mg kg−1 body weight per day orally, once daily for 180 consecutive days. Testes were removed from control and experimental animals surgically on the 90th, 120th, and 180th day. On the 180th day of the treatment, a maximum number of seminiferous tubules became atrophic, and vacuolization of germinal epithelium, and sloughing of the germinal epithelium and sertoli cells was more marked as compared to days 90 and 120. Some of the seminiferous tubules were devoid of germinal cells. These pathological findings were supported by ultrathin and electron microscopic examination. On the basis of the present investigation it could be concluded that chronic exposure of carbendazim in male goats did not allow proper maturation of testis.